Authors


Neelesh Agarwal, PharmD

Latest:

Discussing Outpatient COVID-19 Treatments

Here is a look at some of the treatment alternatives, which can offer simpler logistics and cost considerations.


Destiny O. Okpomo, PharmD Candidate

Latest:

Bioaccumulation of Drugs by Human Gut Bacteria Can Affect Drug Availability

A new study demonstrated that gut organisms can alter drug availability by biotransformation on a significantly broader scale than previously expected.


Jenna E. Januszka, PharmD

Latest:

Gender-Affirming Care in Persons Living With HIV

Gender-affirming hormone therapy (GAHT) therapy consists of administration of exogenous hormones and suppression of endogenous hormone production, with the goal of obtaining characteristics more congruent with an individual’s gender identity. Here is a review of these therapies and consideration for PrEP and the risks associated with HIV in this diverse population.



Ryan P. McNamara, PhD

Latest:

Influenza Virus Is Primed for Continual Emergence and Pandemic Potential

The broad host range and natural reassortment of the influenza virus has played an instrumental role in previous pandemics, and the virus is poised for future large-scale outbreaks.


Tess Wiskel, MD

Latest:

Climate Change Effects on Vector-Borne Disease: The Case of Lyme

With evolving weather patterns, the natural habitat of ticks is expanding, and more people are becoming susceptible to them.


Steven Murdoch, MD

Latest:

Disseminated Gonococcal Infection Complicated by Suspected Osteomyelitis of Humeral Head

Gonococcal septic polyarthritis is an uncommon manifestation of N gonorrhoeae infection, but has increased by about 40% in recent years.


Y. Vivian Tsai, PharmD

Latest:

Precision Dosing of To-Marrow: Linezolid Therapeutic Drug Monitoring

Emerging literature suggests therapeutic drug monitoring for this antimicrobial to minimize the risk for linezolid-associated toxicities while maintaining efficacy in select populations.


Jeff Goad, PharmD, MPH

Latest:

COVID-19 Booster Shots and the Future

Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.


Sara Groome, PharmD, BCIDP

Latest:

Restoring Hope by Restoring Gut Flora: Rebyota and the Future of Combating Recurrent CDI

Although fecal microbiota, live-jslm (Rebyota; RBX2660) is the first fecal microbiota product approved by the FDA, there are other microbiota-based agents in the pipeline.


Angela Rasmussen, PhD

Latest:

COVID-19 Booster Shots and the Future

Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.


Keith Lee

Latest:

Final Diagnosis: Pott Puffy Tumor With Subdural Empyema

A rare case of Pott puffy tumor occurs in an atypical patient with no risk factors, likely due to untreated sinus infection.


Seth Lederman, MD

Latest:

Our Price for Not Aiming Higher: Long COVID Is Here to Stay

Guest author Seth Lederman, MD, calls Long COVID "one of the most pressing global health threats I have seen since fighting HIV/AIDS."


Laya Manoj

Latest:

Disseminated Gonococcal Infection Complicated by Suspected Osteomyelitis of Humeral Head

Gonococcal septic polyarthritis is an uncommon manifestation of N gonorrhoeae infection, but has increased by about 40% in recent years.


Randi Silibovsky, MD

Latest:

Community-Acquired Candida Glabrata Empyema: An Atypical Diagnosis Not to Miss

Although this patient had none of these common risk factors associated with Candida empyema, she did have other factors predisposing her to fungal colonization and subsequent infection.


Fidelia Bernice, PharmD, BCIDP

Latest:

Daptomycin as Frontline Therapy for MRSA Bacteremia: Has the Time Come?

Findings increasingly suggest the mortality risk may be reduced by initiating daptomycin within 3 days of infection.


Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP

Latest:

Practice Pearls for Treatment of Respiratory Infections

Tina Tan, MD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Priya Nori, MD; Jacinda Abdul-Mutakabbir, PharmD; and Kevin Michael Reiter, MD, PA, provide key takeaways from the discussion on the treatment of respiratory viral infections.


Leanna Liu, PharmD, BCIDP, BCPS

Latest:

Amped-up Enterobacterales Debate

Demystifying clinical data for treating invasive AmpC-harboring Enterobacterales.


Mina Seo

Latest:

Impact of Inpatient Pharmacist Review of Discharge Antibiotics

A food for thought as an ambulatory antibiotic stewardship initiative.


Amy L. Brotherton, PharmD, AAHIVP, BCIDP

Latest:

Ready, Set, Cabenuva: Implementing Cabotegravir/Rilpivirine

This novel therapeutic option represents the first long-acting injectable approved for maintenance of HIV-1 suppression.


Sarah B. Minor, PharmD, MHA, BCPS-AQ ID

Latest:

The Next Generation of COVID-19 Vaccines and Boosters

Will there be an answer to keep the continuously evolving virus at bay? Are seasonal combination vaccines the wave of the future?


Sahil Khanna, MBBS, MS

Latest:

Looking Toward the Future of CDI Management

Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.


Aaron Hamby, PharmD

Latest:

Increase in Enteroviruses Seen with Decreases in COVID-19 Precautions

The Centers for Disease Control and Prevention (CDC) reports the rise in pediatric acute respiratory illnesses especially as there is a decrease in hygiene measures that were previously employed during the pandemic.


Louise-Marie Oleksiuk, PharmD, BCPS

Latest:

Daptomycin as Frontline Therapy for MRSA Bacteremia: Has the Time Come?

Findings increasingly suggest the mortality risk may be reduced by initiating daptomycin within 3 days of infection.


Mehrnaz Sadrolashrafi, PharmD, BCCCP

Latest:

COVID-19–Associated Fungal Infections During EMCO: Review of Epidemiology, Diagnosis, and Pharmacotherapy

Examining pharmacological management in COVID-19 patients with ARDS requiring antifungal therapy during extracorporeal life support.


Zachary Hitchcock, PharmD Candidate; and J. Drew Zimmer, PharmD, BCPS, *SIDP

Latest:

Getting Help from HAL: Applying Machine Learning to Predict Antibiotic Resistance

A pair of experts assess literature on the means of interpreting hospitalized patient antibiotic resistance through machine learning.



Jason Hedvat, PharmD, BCIDP

Latest:

To Prophylax or not to Prophylax: Preventing CDI

Clinicians look at optimal approaches for trying to avoid Clostridioides difficile infection (CDI).


Kayla Stover, PharmD, BCIDP, BCPS, FCCP, FIDSA

Latest:

Top 5 Tips for Teaching ID Learners

The latest article from SIDP offers a Top 5 list of how to precept a learner on an infectious disease rotation.


Brian Lu, PharmD

Latest:

Combination Antifungal for Invasive Mucormycosis: Yay or Nay?

There is limited and conflicting data regarding the role of combination antifungal therapy for treatment of invasive mucormycosis.

© 2023 MJH Life Sciences

All rights reserved.